METTL3 and colorectal carcinoma: This boost in METTL3 enhances the m6A modification on mothers against decapentaplegic (MAD)-related protein 7(SMAD7) mRNA, reducing its stability, decreasing SMAD7 protein synthesis, and promoting CRC cell metastasis [98].